Implementing HPV Vaccination Services in People Living with HIV in Trinidad and Tobago: A Brief Report
Results suggest that by implementing comprehensive and targeted programs, clinics have the potential to successfully implement HPV vaccinations toward significantly reducing the incidence and mortality of HPV-related cancers and saving lives. There is a trend with the highest vaccination uptake during the peak years of COVID-19 vaccinations, with HPV vaccination rates almost doubling between 2019 and 2021. Hence, our data suggest that the COVID-19 vaccination program may have boosted HPV vaccination.
Authors
- Gregory Boyce (ORCID: https://orcid.org/0000-0002-2434-4612)
- Robert J. Edwards (ORCID: https://orcid.org/0000-0002-4392-8998)
- Gaole Song (ORCID: https://orcid.org/0000-0002-6163-6817)
- Selena Todd
- Kimlin Ashing (ORCID: https://orcid.org/0000-0002-6209-508X)
- Jonathan Edwards (ORCID: https://orcid.org/0000-0001-5334-821X)
- Tessa Galindo
- Sharon Soyer
Institutions
- City Of Hope National Medical Center (US)
- University of Trinidad and Tobago (TT)
- American Association For Cancer Research (US)
- Port of Spain General Hospital (TT)
- College of Science, Technology and Applied Arts of Trinidad and Tobago (TT)
- City of Hope (US)
Publication Details
- Journal
- Cancer Epidemiology Biomarkers & Prevention
- Published
- 2025-05-01
- DOI
- https://doi.org/10.1158/1055-9965.epi-24-1611
- Primary Topic
- Vaccine Coverage and Hesitancy
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Division of Cancer Prevention, National Cancer Institute